ScienceDex / Researcher record
Henderson, Mark
- National Center for Advancing Translational Sciences (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $1,707,389 | 7 | #4,344 |
| 2022 | $3,186,105 | 14 | #1,590 |
| 2023 | $2,138,147 | 13 | #3,365 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected7 records
- FY202214 records
- FY202313 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Henderson, Mark as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000419-02ZIAContact PIEmetine for SARS-CoV-2$737.8Kaward amount
- 1ZIATR000405-02ZIAContact PIHigh-throughput screening to identify inhibitors of breast-to-brain metastasis$202Kaward amount
- 1ZIATR000404-02ZIAContact PIHigh-throughput screening to identify modulators of PKD2 function$202Kaward amount
- 1ZIATR000428-02ZIAContact PIAMPK synthetic activators$202Kaward amount
- 1ZIATR000431-01ZIAContact PIEvaluation of cAbl allosteric inhibitors in brain cancer$121.3Kaward amount
- 1ZIATR000432-01ZIAContact PIEvaluation of cAbl allosteric inhibitors in Gaucher-Parkinson$121.3Kaward amount
- 1ZIATR000433-01ZIAContact PINMR characterization of binding of allosteric cAbl inhibitors$121.3Kaward amount
Award organization
Organizations that administered FY2021 awards listing Henderson, Mark as a PI.
FY2021 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardNational Center for Advancing Translational Sciences
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #4344
- 2021Entered Top 25% NationallyRanked #4344
- 2022$2M Cumulative Funding
- 2022Entered Top 10% NationallyRanked #1590
- 2023$5M Cumulative Funding